Cargando…
Conjugate of PAMAM Dendrimer, Doxorubicin and Monoclonal Antibody—Trastuzumab: The New Approach of a Well-Known Strategy
The strategy utilizing trastuzumab, a humanized monoclonal antibody against human epidermal growth receptor 2 (HER-2), as a therapeutic agent in HER-2 positive breast cancer therapy seems to have advantage over traditional chemotherapy, especially when given in combination with anticancer drugs. How...
Autores principales: | Marcinkowska, Monika, Sobierajska, Ewelina, Stanczyk, Maciej, Janaszewska, Anna, Chworos, Arkadiusz, Klajnert-Maculewicz, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414888/ https://www.ncbi.nlm.nih.gov/pubmed/30966223 http://dx.doi.org/10.3390/polym10020187 |
Ejemplares similares
-
Multicomponent Conjugates of Anticancer Drugs and Monoclonal Antibody with PAMAM Dendrimers to Increase Efficacy of HER-2 Positive Breast Cancer Therapy
por: Marcinkowska, Monika, et al.
Publicado: (2019) -
Molecular Mechanisms of Antitumor Activity of PAMAM Dendrimer Conjugates with Anticancer Drugs and a Monoclonal Antibody
por: Marcinkowska, Monika, et al.
Publicado: (2019) -
Sugar Modification Enhances Cytotoxic Activity of PAMAM-Doxorubicin Conjugate in Glucose-Deprived MCF-7 Cells – Possible Role of GLUT1 Transporter
por: Sztandera, Krzysztof, et al.
Publicado: (2019) -
Intrinsic Fluorescence of PAMAM Dendrimers—Quenching Studies
por: Konopka, Malgorzata, et al.
Publicado: (2018) -
Unusual Enhancement of Doxorubicin Activity on Co-Delivery with Polyhedral Oligomeric Silsesquioxane (POSS)
por: Sobierajska, Ewelina, et al.
Publicado: (2017)